NCT00051506已完成2 期
ALIMTA(Pemetrexed)/Cisplatin and ALIMTA(Pemetrexed)/Carboplatin in Extensive Stage Small Cell Lung Cancer.
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 试验地点
- 8
研究概览
简要总结
The purpose of this study is to evaluate the effects (good and bad) of ALIMTA plus Carboplatin or ALIMTA plus Cisplatin on you and your small cell lung cancer.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Have a diagnosis of extensive stage small cell lung cancer and can be treated with chemotherapy.
- •Have received no prior chemotherapy for your disease.
- •Have at least one measurable lesion.
- •have an adequate performance status.
- •Sign an informed consent form.
排除标准
- •Have previously received chemotherapy for your lung cancer.
- •Have been treated with a investigational drug within the last 30 days. Have previously completed or withdrawn from this study or any other study investigating ALIMTA.
- •Have received radiation therapy within the last 1-2 weeks.
- •Have brain metastasis that is uncontrolled.
- •Have active infection or other serious condition.
研究者
研究点 (8)
Loading locations...
相似试验
Approved For Marketing
不适用
ALIMTA (Pemetrexed) Alone or in Combination With Cisplatin for Patients With Malignant Mesothelioma.MesotheliomaNCT00040625Eli Lilly and Company
已完成
2 期
Pemetrexed and Carboplatin in Locally Advanced or Metastatic Breast CancerNeoplasm MetastasisBreast CancerNCT00072865Eli Lilly and Company50
已完成
3 期
A Randomized Phase 3 Trial of Pemetrexed and Cisplatin Versus Gemcitabine and Cisplatin in Patients With Locally Advanced or Metastatic Non Small Cell Lung CancerNon Small Cell Lung CarcinomaNCT00087711Eli Lilly and Company1,713
已完成
2 期
ALIMTA Plus Carboplatin as Front-Line Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer: A Phase 2 Clinical Trial.Carcinoma, Non-Small-Cell LungNCT00051493Eli Lilly and Company50
已完成
1 期
Trial of Pemetrexed and Carboplatin in Patients With Recurrent Ovarian or Primary Peritoneal CancerPrimary Peritoneal CancerOvarian CancerNCT00489359Eli Lilly and Company86